Evidence map›Paper›PMID 21561773›Full record

ArticleTrends in microbiology2011

Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier.

Kyu Y Rhee, Luiz Pedro Sorio de Carvalho, Ruslana Bryk, Sabine Ehrt, Joeli Marrero, Sae Woong Park, Dirk Schnappinger, Aditya Venugopal, Carl Nathan

Open access · greenAbstract read
In one paragraph

Article in Trends in microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 168 citations in OpenAlex.

  1. A Pilot Proteomics Analysis ofInternational journal of molecular sciences · 2026
    Article
  2. mSystems · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Pathogens (Basel, Switzerland) · 2023
    Article
  11. Article
  12. One-shotMolecular systems biology · 2023
    Article
  13. Review
  14. Article
  15. Host- and Age-Dependent Transcriptional Changes inInternational journal of molecular sciences · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Actinobacteria challenge the paradigm: A unique protein architecture for a well-known, central metabolic complex.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Contribution of NmSystems · 2021
    Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kyu Y RheeDepartment of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. kyr9001@med.cornell.edu
Luiz Pedro Sorio de Carvalho
Ruslana Bryk
Sabine Ehrt
Joeli Marrero
Sae Woong Park
Dirk Schnappinger
Aditya Venugopal
Carl Nathan
Cornell University · US

Funding

Targets in Mycobacterium Tuberculosis: Stress Resistance & RepairR01AI064768 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI NATHAN, CARL FRANCIS · 2005 to 2015
$8.6M
Conditional Expression of Mycobacterial GenesR01AI063446 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI EHRT, SABINE · 2006 to 2022
$7.2M
Metabolomics approaches to TB drug developmentR21AI081094 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI RHEE, KYU Y · 2009 to 2010
$462k
NIAID NIH HHS AI064768NIAID NIH HHS AI081094NIAID NIH HHS AI63446NIAID NIH HHS R01 AI063446NIAID NIH HHS R01 AI064768NIAID NIH HHS R21 AI081094
6 · The paper itself

Abstract

Recent advances in liquid chromatography and mass spectrometry have enabled the highly parallel, quantitative measurement of metabolites within a cell and the ability to trace their biochemical fates. In Mycobacterium tuberculosis (Mtb), these advances have highlighted major gaps in our understanding of central carbon metabolism (CCM) that have prompted fresh interpretations of the composition and structure of its metabolic pathways and the phenotypes of Mtb strains in which CCM genes have been deleted. High-throughput screens have demonstrated that small chemical compounds can selectively inhibit some enzymes of Mtb's CCM while sparing homologs in the host. Mtb's CCM has thus emerged as a frontier for both fundamental and translational research.

Indexed as

Genes, BacterialAnti-Bacterial AgentsBiosynthetic PathwaysCarbonComputational BiologyEvolution, MolecularGenomicsMetabolomicsMycobacterium tuberculosisAnti-Bacterial AgentsCarbon

Identifiers

PMID21561773
PMCPMC3601588
OpenAlexW1971540852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.